RARITAN, N.J., May 17, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the results of an investigational Phase 3 study suggesting NUCYNTA® ER (tapentadol) extended-release tablets were ...

Washington, April 23 (IANS) People with non-alcoholic fatty liver disease (NALFD) who consume a peg or two daily are half as likely to develop hepatitis as non-alcoholics with the same condition, says a new study.

Bay County Circuit and Probate courts began drug treatment programs designed to tackle addictions to illegal and controlled substances in October.

Acetaminophen, the active ingredient in Tylenol, is popular. Because of familiarity with acetaminophen, many are not aware that Tylenol, and other forms of acetaminophen, carries risk for significant health affects. For example, acetaminophen can cause serious liver damage and links … Continue reading →